Rare Cases of Contrast-Induced Encephalopathies. 2020

Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
Department of Neurosurgery, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.

Cortical blindness (CB) due to contrast-induced encephalopathy is a rare complication in endovascular procedure. Although exact mechanism is not known, disruption of blood-brain barrier (BBB) by contrast agent is supposed to be caused. We report two cases of contrast-induced encephalopathies after coil embolization of unruptured aneurysm. A 68-year-old woman with unruptured basilar artery aneurysm was treated with endovascular stent-assisted coil embolization. The procedure was successfully accomplished within 172 min using about 160 ml of contrast medium (iopamidol). However, she manifested with CB 3 h after the procedure and seizure on the next day. Immediate computed tomography revealed the cortical enhancement in both occipital lobes. Diffusion-weighted imaging-magnetic resonance imaging and fluid-attenuated inversion recovery sequence 1 day after the procedure revealed edema in both occipital lobes with no findings of ischemia or hyperperfusion. Electroencephalography showed sharp and slow waves in both occipital lobes. She required endotracheal intubation on day 2 to maintain airways and breathing. Her sensorium improved 4 days after the procedure with administration of steroid and anticonvulsant. She was extubated on day 4 after the procedure. She was discharged with persisting CB as a sequel.

UI MeSH Term Description Entries

Related Publications

Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
January 1961, Neurologia, neurochirurgia i psychiatria polska,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
October 1970, La Presse medicale,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
October 2020, Lakartidningen,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
January 2017, American journal of therapeutics,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
December 1977, Lyon medical,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
February 2024, The Lancet. Neurology,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
October 1974, La Nouvelle presse medicale,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
March 2022, Epilepsy & behavior : E&B,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
January 2007, Epilepsia,
Kazutaka Nakao, and Girish Joshi, and Yuichi Hirose, and Riki Tanaka, and Yasuhiro Yamada, and Kyosuke Miyatini, and Binoy Damodar Thavara, and Tsukasa Kawase, and Yoko Kato
September 2022, Cureus,
Copied contents to your clipboard!